Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
"Dosage," "reconstitution," and "blend dosing" are three distinct intents
The standard KLOW dose for women remains 3.2 mg per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV
Laboratory research record on Cagrilintide [PMID: 41052437] PubMed laboratory record discussing Cagrilintide in a research context
KPV appears to exert its effects via the peptide transporter PepT1 rather than classical melanocortin receptors
Use With Caution / Additional Monitoring in Research Contexts Because Glow Blend combines GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4 fragment), and is researched for its interaction with regenerative, collagen-related, tissue-maintenance, recovery-focused, and physiological-resilience pathways, certain higher-frequency or complex experimental protocols may warrant additional monitoring and individualized evaluation
US$ 23.08
US$ 22.94
